DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology Market Size, Share, Trends, By Technology, By Tools, By Application, By End-use, and By Region Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
According to a new report, the Synthetic Biology Market size was valued at USD 9.26 Billion in 2021 and is estimated to exceed USD 75.9 Billion in terms of revenue, at a CAGR of 26.3% through 2030. Synthetic biology is an emerging field of science that deals with the design and construction of artificial biological systems for various applications. The market for synthetic biology is expected to grow at a rapid pace owing to the increasing demand for synthetic genes, proteins, and other biomolecules in the pharmaceutical and biotechnology industries.
Products produced by synthetic biology are used in pharmaceutical and biotechnology research, as well as industrial applications. Increasing government funding for synthetic biology research and the ever-expanding application areas of synthetic biology are the major drivers of this market.
Synthetic biology has a potential in DNA sequencing, genetic engineering, and other biotechnology applications. It is anticipated that the demand for synthetic biology will rise in the pharmaceutical and biotech industries for the development of new therapeutic proteins and designer microbes.
Increased amount of study data generation with dipping prices of DNA sequencing, rise in government funding and initiatives, and need for efficient disease management are the prominent drivers of the synthetic biology market. In addition, new applications in healthcare and pharmaceutical industry is another significant factor that is anticipated to fuel the growth of this market during the forecast period.
Market Dynamics
Market Drivers
- Rapid Technological Advancements in the Field of Synthetic Biology
- Diverse Range of Synthetic Biology-Based Applications Leading to Widespread Adoption in the Biotechnology and Pharmaceutical Industries
- Rising Investments Toward Research & Development (R&D) Activities for Synthetic Biology-Based Research
Market Restraints
- Potential Biosafety, Biosecurity, and Ethical Issues Related to the Unintended or Deliberate Misuse of Synthetic Biology Techniques
- Stringent Government Regulations & Guidelines
Market Segmentation
Technology Outlook (Revenue, USD Billion; 2019-2030)
- Nucleotide synthesis and sequencing
- Genome engineering
- Integrated systems
- Microfluidics
- Functional genomics
Tools Outlook (Revenue, USD Billion; 2019-2030)
- Synthetic DNA and Oligonucleotides
- Enzymes
- Synthetic Cells
- Chassis Organisms
- Xeno-nucleic Acids
Application Outlook (Revenue, USD Billion; 2019-2030)
- Medical & Healthcare Application
- Artificial Tissue & Tissue Regeneration
- Environment & Agriculture
- Bioprocess Industry
End-use Outlook (Revenue, USD Billion; 2019-2030)
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutions
- Others
Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Key Topics Covered:
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Synthetic Biology Market Segmentation & Impact Analysis
Chapter 5. Synthetic Biology Market By Technology Insights & Trends
Chapter 6. Synthetic Biology Market By Tools Insights & Trends
Chapter 7. Synthetic Biology Market By Application Insights & Trends
Chapter 8. Synthetic Biology Market By End-use Insights & Trends
Chapter 9. Synthetic Biology Market Regional Outlook
Chapter 10. Competitive Landscape
Chapter 11. Company Profiles
Companies Mentioned
- Amyris Inc.
- Ginkgo Bioworks
- Codexis Inc.
- Novozymes AG
- Twist Biosciences
- GenScrip Corporation.
- Merck KGaD
- Codex DNA Inc.
- Eurofins Scientific Inc.
- Amgen Inc.
For more information about this report visit https://www.researchandmarkets.com/r/tzm8hw
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900